Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Seminoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Medulloblastoma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hearing Loss 1Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 15Specimen Handling 13Cisplatin 13pembrolizumab 10Radiotherapy, Intensity-Modulated 9Carboplatin 9Platinum 81,2-diaminocyclohexaneplatinum II citrate 8Cetuximab 7Radiotherapy 5Radiation 5Paclitaxel 5Biopsy 5Taxes 4(225)Ac-DOTA-c(RGDyK) 4cemiplimab 3Docetaxel 3ipatasertib 2durvalumab 2X-Rays 2Surgical Procedures, Operative 2Standard of Care 2Interviews as Topic 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Drug Therapy 2Disulfides 2Chemoradiotherapy 2trametinib 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Laryngeal Neoplasms × Hearing × 1 year × Clear all
NCT06662058 2026-04-23

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Emory University

Phase NA Recruiting
118 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡